Global Neurovascular Devices Market

The Global Neurovascular Devices Market is valued at approximately USD 3.32 billion in 2024 and is projected to expand at a healthy CAGR of 6.90% during the forecast period of 2025–2035, with historical benchmarks spanning 2023 and 2024 and 2024 designated as the base year for estimation. Neurovascular devices are specialized medical technologies engineered to diagnose, treat, and manage disorders affecting the blood vessels of the brain, including strokes, aneurysms, and vascular malformations. These devices play a decisive role in minimally invasive neurosurgical interventions, enabling clinicians to restore blood flow, prevent hemorrhagic events, and improve patient outcomes while reducing procedural risks and recovery times. The market’s growth trajectory is being shaped by rising neurological disease prevalence, aging populations, and continuous advancements in endovascular treatment techniques.

An escalating global burden of ischemic strokes and cerebral aneurysms has significantly stepped up demand for neurovascular interventions, thereby pulling through the adoption of advanced devices. Healthcare systems are increasingly shifting toward minimally invasive procedures to lower hospitalization costs and enhance clinical efficiency, which in turn is fueling investment in next-generation neurovascular technologies. Furthermore, improved diagnostic imaging, growing awareness around early stroke management, and expanding access to specialized care centers are opening new pathways for market expansion. Despite these tailwinds, high device costs and stringent regulatory approval processes remain notable barriers, particularly in developing healthcare economies, across the forecast period of 2025–2035.

The detailed segments and sub-segments included in the report are

By Type

• Neurothrombectomy Devices
• Embolization Devices
• Angioplasty Devices

By Application

• Ischemic Stroke
• Aneurysm
• Stenosis
• Arteriovenous Malformations (AVMs)

By End User

• Hospitals and Specialty Clinics
• Ambulatory Care Centers
• Other End Users

By Region

North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific

• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America

• Brazil
• Mexico

Middle East & Africa

• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Neurothrombectomy devices are expected to dominate the Global Neurovascular Devices Market, accounting for the largest share throughout the forecast horizon. This dominance is primarily attributed to their critical role in acute ischemic stroke management, where rapid clot retrieval can dramatically improve survival rates and neurological outcomes. As stroke care protocols increasingly emphasize early intervention and mechanical thrombectomy adoption widens across hospitals, demand for these devices continues to scale up. Embolization and angioplasty devices, while essential in complex vascular interventions, are witnessing comparatively steady yet slower growth.

From a revenue contribution standpoint, ischemic stroke applications currently lead the market, driven by the rising incidence of stroke globally and the growing availability of advanced endovascular treatment options. Hospitals and specialty clinics are investing heavily in neurovascular infrastructure to handle increasing emergency caseloads, thereby reinforcing revenue generation from stroke-related interventions. Aneurysm treatment follows closely, supported by technological refinements in embolization materials and delivery systems, while applications addressing stenosis and AVMs continue to gain traction as diagnostic capabilities improve.

North America held a dominant position in the Global Neurovascular Devices Market in 2024, supported by a well-established healthcare infrastructure, high adoption of advanced medical technologies, and strong reimbursement frameworks for neurointerventional procedures. Europe represents another significant market, driven by increasing stroke awareness programs and favorable clinical research environments. Asia Pacific is anticipated to witness the fastest growth over the forecast period, fueled by rising healthcare expenditure, improving access to specialized neurological care, and a rapidly growing patient pool in countries such as China and India. Meanwhile, Latin America and the Middle East & Africa are gradually emerging as growth markets as investments in healthcare modernization continue to gather pace.

Major market players included in this report are

• Medtronic plc
• Stryker Corporation
• Boston Scientific Corporation
• Johnson & Johnson (Cerenovus)
• Terumo Corporation
• Penumbra, Inc.
• MicroVention, Inc.
• Cook Medical
• Merit Medical Systems, Inc.
• Integra LifeSciences Holdings Corporation
• Balt Group
• Rapid Medical
• Phenox GmbH
• W. L. Gore & Associates, Inc.
• Lepu Medical Technology Co., Ltd.

Global Neurovascular Devices Market Report Scope

• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent to up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes across various segments and countries in recent years and to forecast their evolution over the coming decade. The report integrates qualitative insights with quantitative analysis to examine the drivers, restraints, and opportunities shaping the Global Neurovascular Devices Market. It also delivers a comprehensive assessment of the competitive landscape, detailing product portfolios, strategic initiatives, and innovation pipelines of key players, while highlighting attractive micro-markets where stakeholders can channel investments for sustained long-term growth.

Key Takeaways

• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of the competitive structure of the market.
• Demand side and supply side analysis of the market.